HomeSTX • LON
add
Shield Therapeutics PLC
Previous close
GBX 4.60
Day range
GBX 4.40 - GBX 4.80
Year range
GBX 2.10 - GBX 5.87
Market cap
46.98M GBP
Avg Volume
2.57M
P/E ratio
-
Dividend yield
-
Primary exchange
LON
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 10.02M | 114.60% |
Operating expense | 9.14M | -17.47% |
Net income | -5.85M | 43.43% |
Net profit margin | -58.38 | 73.64% |
Earnings per share | — | — |
EBITDA | -4.27M | 56.60% |
Effective tax rate | -5.67% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.52M | -53.23% |
Total assets | 57.48M | 17.79% |
Total liabilities | 58.80M | 74.13% |
Total equity | -1.32M | — |
Shares outstanding | 1.04B | — |
Price to book | ∞ | — |
Return on assets | -19.17% | — |
Return on capital | -43.98% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -5.85M | 43.43% |
Cash from operations | -1.60M | 81.40% |
Cash from investing | -673.00K | -21.04% |
Cash from financing | 1.66M | -82.97% |
Net change in cash | -787.50K | -544.92% |
Free cash flow | -3.61M | 43.13% |
About
CEO
Founded
2008
Website
Employees
63
